Ebit تغيير تاريخ
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 3.53B 2.42B 2026-03
Essilor EUR 2.3B 919M 2026-06
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 268M 395M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 249M 103.11M 2026-03
Lonza CHF 673M 54M 2025-06
Merck EUR 1.05B 572M 2026-03
Novartis USD 4.73B 549M 2026-06
Philips EUR 641M 339M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06
Smith & Nephew USD 440M 50M 2025-12
Sonova Holding CHF 296.8M 156.9M 2025-12
UCB EUR 1.29B 571M 2025-12